Endometrial Stromal Sarcoma Presenting as Prevesical Mass Mimicking Urachal Tumor by Jung, Seung Il et al.
INTRODUCTION
Endometrial stromal sarcoma (ESS) is a rare neoplasm com-
prising only 0.2% of all uterine malignancies and usually occ-
urs as a primary tumor of the uterine corpus (1).
ESS of extrauterine origin is a very rare type of neoplasm
and arises in sites, such as the ovary, the pelvic cavity, mesen-
tery, omentum, and serosal or intramural portion of the large
intestine (2-4). The tumor is usually classified into two sub-
types, low-grade ESSs and undifferentiated sarcomas with the
latter subtype carrying a very poor prognosis (5, 6).
We describe a 60-yr-old woman with low-grade ESS pre-
sented as prevesical mass mimicking urachal mass.
CASE REPORT
A 60-yr-old woman presented with incidentally detected
prevesical mass. Her history was remarkable in that she had
a total hysterectomy by lower median abdominal incision for
endometriosis 11 yr ago. The family history was unremark-
able. Physical examination showed no palpable abdominal
mass. Routine blood tests, blood chemistry and urine test
revealed no abnormal findings. In the previous ultrasonogra-
phic examination, heterogeneous hyperechoic pelvic mass was
incidentally detected, and she was transferred to our hospital
on the impression of urachal tumor (Fig. 1A). 
Magnetic resonance imaging of the abdomen and pelvis
showed a mass located anterior to the bladder in the prevesi-
cal space of Retzius and helped to establish the relation of
the tumor to the bladder in the sagittal plane (Fig. 1B).
Complete excision with bladder sparing was successful by
lower median abdominal incision. At surgery, two tumor ma-
sses were founded in the prevesical space of retzius and had
not infiltrated the wall of the bladder and urachus.
Grossly, well-circumscribed yellowish tumors were 4.5×
2.5×2 cm, 1.5×1×1 cm in size, respectively. Microscop-
ically, the lesion was characterized infiltrating nest of tumor
cells. The tumor consisted of relatively large cells resembling
those of the endometrial stroma, which encircled small vessels
(Fig. 2A). Tumor cell nuclei was round to ovoid and a small
amount of cytoplasm was present. Mitotic activity was less
than 10 mitotic figures per 10 high power field (HPF) (Fig.
2B). Immunohistochemically, the tumor cells were positive
for CD10 but negative for cytokeratin. Most of the cells were
also negative for estrogen receptor, and positive for proges-
terone receptor (data not shown). Based on these findings, a
low-grade ESS was diagnosed. Her postoperative recovery
was uneventful. She was free of symptoms at the last follow-
up, 15 months after the abdominal surgery, with no evidence
of recurrence.
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Endometrial Stromal Sarcoma Presenting as Prevesical Mass 
Mimicking Urachal Tumor
Endometrial stromal sarcoma (ESS) is a mesenchymal neoplasm that usually occurs
as a primary tumor of the uterine corpus, but rarely arises in other sites, such as the
ovary,  pelvic cavity, mesentery, omentum and intestine. Herein, we present a rare
case of low-grade ESS presented as prevesical mass. A 60-yr-old woman who had
undergone total hysterectomy for endometriosis eleven years ago was presented
with incidentally detected prevesical pelvic mass. Since malignant transformation
of urachal remnants was possible, the mass was suspected to be a urachal tumor.
Extraction of the mass was performed, and the histopathologic diagnosis was low-
grade ESS. In summary, prevesical tumor is rare but in patients with endometriosis,
we suggest endometriosis and its possible malignant changes should be taken into
account in the differential diagnosis of prevesical mass. 
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ESS usually occurs as a primary tumor of the uterine cor-
pus and is rare neoplasm. ESS of extrauterine origin is very
rare. Because of the rarity of ESS, very little is known about
its pathogenesis. However, there have been some reports in
which ESS is considered to be associated with endometriosis
(2-4). It arises in area of pre-existing endometriosis and also
arises in cases that are not associated with endometriosis.
These are explained by two hypotheses. One is malignant
transformation of endometriosis. Various types of neoplasm
have been observed in patients with endometriosis.
Histologically, endometrial adenocarcinoma is the most
(about 70%), and sarcoma is the second common malignancy
(12%) (7). But exact incidence of ESS in endometriosis is not
well described. Heaps et al. (7) reported that malignant tumor
arising in endometriosis involved ovary (78.7%) and extrag-
onadal site (21.3%).
Majority of extragonadal sites were rectovaginal septum
(4.3%), colon (4.3%), vagina (2%), and pelvic peritoneum
(5.7%). The other theory is a de novo tumor, potentially deri-
ved from submesothelial pluripotential Mullerian cells. The
pluripotential Mullerian epithelium is considered to be wide-
ly distributed in the abdominal and pelvic cavities (4).
In the present case, the patient had undergone total hysterec-
tomy for endometriosis 11 yr ago, and the tumor was local-
ized in the prevesical space. So, we assumed that it arose from
prevesical endometriosis because the patient had a history of
endometriosis but there is no direct evidence.
Previously, the tumor is usually classified into two categories,
low and high-grade, based on differences in mitotic activity,
with the latter subtype carrying a very poor prognosis (5).
Recently, the World Health Organization classification for
tumors of the uterus classifies the tumors based primarily
on tumor margin status and cytologic features (6). Low-grade
ESSs are clinically indolent malignancies with minimal cyto-
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Fig. 1. Imaging studies. (A) Ultrasonograhy shows heterogeneous hyperechoic pelvic mass. (B) Magnetic resonance imaging sagittal T2-
weighted image shows well-defined hyperintense mass (arrow) in prevesical space and sagittal T1-weighted gadolinium-enhanced image
shows homogeneous enhancement of the mass (arrow).
A B
Fig. 2. Pathologic findings. (A) The tumor cells are distributed around the small vessels. (B) Tumor cells have oval nuclei and scanty cyto-
plasm with ill-defined cell borders. The cells are atypical and mitotic figures are noted.
A B 25 μ m 50 μ mlogic atypia and proliferative activity. Undifferentiated sar-
comas (previously categorized as high-grade endometrial stro-
mal sarcomas) are highly aggressive malignancies that show
substantial cytologic atypia and high mitotic activity.
Young et al. (3) reported that the mitotic rate of the extrau-
terine ESS correlated with the prognosis but Chang et al. (2)
reported that neither mitotic index nor cytologic atypia in
primary extrauterine ESS were predictive of tumor recurrence
or death from tumor. In their series, 77% of patients whose
tumors had a mitotic index of less than 10 per HPF had one
or more recurrences and 30% died from their neoplasm. The
behavior of the primary extrauterine ESS was more reminis-
cent of high-grade primary uterine ESS than low-grade pri-
mary uterine ESS (2). Therefore, close observation and extend-
ed follow-up will be required in extrauterine ESS, regardless
of mitotic activity.
Low-grade ESS has slow growth and indolent course with
a tendency for late recurrence; approximately 50% of cases of
low-grade ESS develop recurrent disease (6). A relatively long-
term survival, despite tumor dissemination, has been report-
ed in low-grade ESS cases. Both recurrent and metastatic low-
grade sarcomas can be successfully treated with surgical exci-
sion, radiation, progestin therapy, or a combination therapy
(6). Considering highly recurrent nature of extrauterine ESS
or low-grade ESS, a life long follow-up is necessary for this
patient. 
Tumor localized in the prevesical space is very rare but ura-
chal tumor has been most commonly presented in prevesical
space. However, when patient with endometriosis presented
with prevesical mass in Retzius space, endometriosis and its
possible malignant changes should be taken into account in
differential diagnosis.
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